You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Merck
McKinsey
Express Scripts
Harvard Business School

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

SOMA COMPOUND W/ CODEINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Soma Compound W/ Codeine patents expire, and when can generic versions of Soma Compound W/ Codeine launch?

Soma Compound W/ Codeine is a drug marketed by Meda Pharms and is included in one NDA.

The generic ingredient in SOMA COMPOUND W/ CODEINE is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.

Summary for SOMA COMPOUND W/ CODEINE
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:SOMA COMPOUND W/ CODEINE at DailyMed
Drug patent expirations by year for SOMA COMPOUND W/ CODEINE
Paragraph IV (Patent) Challenges for SOMA COMPOUND W/ CODEINE
Tradename Dosage Ingredient NDA Submissiondate
SOMA COMPOUND W/ CODEINE TABLET;ORAL aspirin; carisoprodol; codeine phosphate 012366

US Patents and Regulatory Information for SOMA COMPOUND W/ CODEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms SOMA COMPOUND W/ CODEINE aspirin; carisoprodol; codeine phosphate TABLET;ORAL 012366-002 Jul 11, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKinsey
Dow
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.